RetractedArticleBMJ neurology open2025

Exploring the therapeutic potential of IL-17A inhibition in myasthenia gravis: a retrospective study on secukinumab.

Zhaoxu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.